• Alto Ingredients Reports Fourth Quarter and Full Year 2020 Results

    Источник: Nasdaq GlobeNewswire / 10 мар 2021 15:05:01   America/Chicago

    • Full year 2020 net loss of $16.4 million, which included a $24.4 million impairment charge
    • Full year 2020 Adjusted EBITDA of $67.4 million
    • Total debt reduced by approximately $146 million

    SACRAMENTO, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer of specialty alcohols and essential ingredients, reported its financial results for the fourth quarter and full year ended December 31, 2020.

    “In 2020, we significantly increased production of our profitable specialty alcohols, reduced the impact of unprofitable fuel-grade operations by idling or selling assets, and lowered operating and overhead expenses,” said Mike Kandris, CEO of Alto Ingredients. “These efforts increased our 2020 Adjusted EBITDA to over $67 million, a remarkable achievement that was within our August 2020 guidance. We also significantly improved our balance sheet, reducing our total debt by approximately $146 million during 2020.

    “We are pursuing a more sustainable and profitable path forward, delivering quality products driven by solid consumer demand. We are currently operating plants with an annual production capacity of 290 million gallons, of which 70 million gallons of specialty alcohols are already contracted for 2021. Our transformation is far from complete and with a significantly improved balance sheet, we are actively developing and exploring new build and buy opportunities to grow and expand our business to further increase revenues and profitability while maintaining and controlling expenses. We believe we are well positioned to capitalize on the opportunities ahead to deliver long-term growth for all our stakeholders.”

    Financial Results for the Three Months Ended December 31, 2020 Compared to 2019

    • Net sales were $168.8 million, compared to $357.6 million.
    • Cost of goods sold was $155.2 million, compared to $354.4 million.
    • Gross profit was $13.6 million, compared to $3.2 million.
    • Selling, general and administrative expenses were $6.7 million, compared to $11.8 million.
    • Operating loss was $14.2 million, compared to $37.9 million.
    • Net loss available to common stockholders was $20.5 million, or $0.30 per share, and included an impairment charge of $24.4 million related to the company’s Western assets. This compares to a loss of $41.4 million, or $0.85 per share, for the three months ended December 31, 2019.
    • Adjusted EBITDA was $16.4 million, compared to $1.9 million.
    • Cash and cash equivalents were $47.7 million at December 31, 2020, compared to $19.0 million at December 31, 2019.

    Financial Results for the Full Year 2020 Compared to 2019

    • Net sales were $897.0 million, compared to $1.4 billion.
    • Cost of goods sold was $844.2 million, compared to $1.4 billion.
    • Gross profit was $52.9 million, compared to a gross loss of $9.9 million.
    • Selling, general and administrative expenses were $32.0 million, compared to $35.5 million.
    • Operating income was $9.9 million, compared to an operating loss of $74.7 million.
    • Net loss available to common stockholders was $16.4 million, or $0.28 per share, compared to a loss of $90.2 million, or $1.90 per share.
    • Adjusted EBITDA was positive $67.4 million, compared to negative $1.7 million.

    Fourth Quarter and Full Year 2020 Results Conference Call
    Management will host a conference call at 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time on Thursday, March 11, 2021, and will deliver prepared remarks via webcast followed by a question-and-answer session.

    The webcast for the call can be accessed from Alto Ingredients website at www.altoingredients.com. Alternatively, you may dial the following number up to ten minutes prior to the scheduled conference call time: (877) 847-6066. International callers should dial 00-1 (970) 315-0267. The pass code will be 8599307. If you are unable to participate in the live call, the webcast will be archived for replay on Alto Ingredients website for one year. In addition, a telephonic replay will be available at 2:00 p.m. Eastern Time on Thursday, March 11, 2021 through 11:59 p.m. Eastern Time on Thursday, March 18, 2021. To access the replay, please dial (855) 859-2056. International callers should dial 00-1 (404) 537-3406. The pass code will be 8599307.

    Use of Non-GAAP Measures

    Management believes that certain financial measures not in accordance with generally accepted accounting principles ("GAAP") are useful measures of operations. The company defines Adjusted EBITDA as unaudited net income (loss) attributed to Alto Ingredients, Inc. before interest expense, provision (benefit) for income taxes, asset impairments, loss on extinguishment of debt, purchase accounting adjustments, fair value adjustments, and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss) attributed to Alto Ingredients, Inc. Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company's performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) attributed to Alto Ingredients, Inc. or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool and you should not consider this measure in isolation or as a substitute for analysis of the company's results as reported under GAAP.

    About Alto Ingredients, Inc.
    Alto Ingredients, Inc. (ALTO), formerly known as Pacific Ethanol, Inc., is a leading producer of specialty alcohols and essential ingredients. The company is focused on products for four key markets: Health, Home & Beauty; Food & Beverage; Essential Ingredients; and Renewable Fuels. The company’s customers include major food and beverage companies and consumer products companies. For more information please visit www.altoingredients.com.

    Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
    Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning Alto Ingredients’ plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business. These factors include, among others, adverse economic and market conditions, including for specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; and the effects – both positive and negative – of the coronavirus pandemic and its resurgence or abatement. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the specialty alcohol production and marketing industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ distilleries, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 16, 2020.

    Media Contact:
    Bryon McGregor, Alto Ingredients, Inc., 916-403-2768, mediarelations@altoingredients.com

    Company IR Contact:
    Michael Kramer, Alto Ingredients, Inc., 916-403-2755, Investorrelations@altoingredients.com

    IR Agency Contact:
    Moriah Shilton, LHA Investor Relations, 415-433-3777, Investorrelations@altoingredients.com


       
    ALTO INGREDIENTS, INC.
    CONSOLIDATED STATEMENTS OF OPERATIONS
    (unaudited, in thousands, except per share data)
       
     Three Months Ended
    December 31,
     Year Ended
    December 31,
      2020   2019   2020   2019 
            
    Net sales$168,818  $357,617  $897,023  $1,424,881 
    Cost of goods sold 155,181   354,421   844,164   1,434,819 
    Gross profit (loss) 13,637   3,196   52,859   (9,938)
    Selling, general and administrative expenses (6,735)  (11,823)  (31,980)  (35,453)
    Gain on litigation settlement       11,750    
    Gain on sale of assets 3,223      1,580    
    Asset impairments (24,356)  (29,292)  (24,356)  (29,292)
    Income (loss) from operations (14,231)  (37,919)  9,853   (74,683)
    Loss on debt extinguishment    (6,517)     (6,517)
    Interest expense, net (3,790)  (5,192)  (17,943)  (20,206)
    Fair value adjustments (2,462)     (9,959)   
    Other income (expense), net 271   (147)  750   104 
    Loss before benefit for income taxes (20,212)  (49,775)  (17,299)  (101,302)
    Benefit for income taxes (17)  (20)  (17)  (20)
    Consolidated net loss (20,195)  (49,755)  (17,282)  (101,282)
    Net loss attributed to noncontrolling interests    8,671   2,166   12,333 
    Net loss attributed to Alto Ingredients, Inc.$(20,195) $(41,084) $(15,116) $(88,949)
    Preferred stock dividends$(319) $(319) $(1,268) $(1,265)
    Net loss available to common stockholders$(20,514) $(41,403) $(16,384) $(90,214)
    Net loss per share, basic and diluted$(0.30) $(0.85) $(0.28) $(1.90)
    Weighted-average shares outstanding, basic and diluted 67,512   48,438   58,609   47,384 
                    


     
    ALTO INGREDIENTS, INC.
    CONSOLIDATED BALANCE SHEETS
    (unaudited, in thousands, except par value)
        
     December 31, December 31,
    ASSETS 2020  2019
    Current Assets:  
    Cash and cash equivalents$47,667 $18,997
    Accounts receivable, net 43,491  74,307
    Inventories 41,767  60,600
    Prepaid inventory 891  1,528
    Assets held-for-sale 58,295  69,764
    Derivative assets 17,149  2,438
    Other current assets 4,786  4,430
    Total current assets 214,046  232,064
    Property and equipment, net 229,486  332,526
    Other Assets:  
    Right of use operating lease assets, net 11,046  24,346
    Notes receivable 14,337  
    Assets held-for-sale   16,500
    Intangible assets 2,678  2,678
    Other assets 5,225  4,381
    Total other assets 33,286  47,905
    Total Assets$476,818 $612,495
          


        
    ALTO INGREDIENTS, INC.
    CONSOLIDATED BALANCE SHEETS (CONTINUED)
    (unaudited, in thousands, except par value)
        
     December 31, December 31,
    LIABILITIES AND STOCKHOLDERS’ EQUITY 2020   2019 
    Current Liabilities:  
    Accounts payable – trade$13,047  $29,277 
    Accrued liabilities 11,101   22,331 
    Current portion – operating leases 2,180   3,457 
    Current portion – long-term debt 25,533   63,000 
    Derivative liabilities    1,860 
    Liabilities held-for-sale 19,542   34,413 
    Other current liabilities 15,524   6,060 
    Total current liabilities 86,927   160,398 
       
    Long-term debt, net of current portion 71,807   180,795 
    Operating leases, net of current portion 8,715   21,171 
    Other liabilities 13,134   23,086 
    Total Liabilities 180,583   385,450 
       
    Stockholders’ Equity:  
    Alto Ingredients, Inc. Stockholders’ Equity:  
    Preferred stock, $0.001 par value; 10,000 shares authorized;
        Series A: 0 shares issued and outstanding as of December 31, 2020 and 2019
        Series B: 927 shares issued and outstanding as of December 31, 2020 and 2019
     1   1 
    Common stock, $0.001 par value; 300,000 shares authorized; 72,491 and 55,508 shares
        issued and outstanding as of December 31, 2020 and 2019, respectively
     72   56 
    Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of December 31, 2020 and 2019     
    Additional paid-in capital 1,036,638   942,307 
    Accumulated other comprehensive loss (3,878)  (2,370)
    Accumulated deficit (736,598)  (720,214)
    Total Alto Ingredients, Inc. Stockholders’ Equity 296,235   219,780 
    Noncontrolling Interests    7,265 
    Total Stockholders’ Equity 296,235   227,045 
    Total Liabilities and Stockholders’ Equity$        476,818  $        612,495 
            

    Reconciliation of Adjusted EBITDA to Net Loss

     Three Months Ended
    December 31,
     Years Ended
    December 31,
    (unaudited)          2020 2019 2020 2019
    Net loss attributed to Alto Ingredients, Inc.$(20,195) $(41,084) $(15,116) $(88,949)
    Adjustments:    
    Interest expense, net 3,790   5,192   17,943   20,206 
    Asset impairments* 24,356   21,655   24,356   21,655 
    Fair value adjustments 2,462      9,959    
    Loss on debt extinguishment    6,517      6,517 
    Benefit for income taxes (17)  (20)  (17)  (20)
    Depreciation and amortization expense* 6,015   9,648   30,269   38,880 
    Total adjustments 36,606   42,992   82,510   87,238 
    Adjusted EBITDA$16,411  $1,908  $67,394  $(1,711)
                    
    ________________               
    * Adjusted for noncontrolling interests.               


    Commodity Price Performance

     Three Months Ended
    December 31,
     Years Ended
    December 31,
    (unaudited)          2020
     2019
     2020
     2019
    Production gallons sold (in millions) 49.0   125.4   271.9   491.0 
    Third party gallons sold (in millions) 51.6   70.1   264.4   328.4 
    Total gallons sold (in millions) 100.6   195.5   536.3   819.4 
         
    Production capacity utilization 49%   82%   56%   82% 
         
    Average sales price per gallon$1.72  $1.70  $1.63  $1.61 
    Average CBOT ethanol price per gallon$1.41  $1.42  $1.25  $1.39 
         
    Corn cost – CBOT equivalent$3.79  $3.93  $3.56  $3.83 
    Average basis$0.27  $0.46  $0.28  $0.43 
    Delivered cost of corn$4.06  $4.39  $3.84  $4.26 
         
    Total co-product tons sold (in thousands) 270.0   725.7   1,447.5   2,821.7 
    Co-product return % (1) 42.6%   35.6%   44.1%   35.1% 
    ________________    
    (1) Co-product revenue as a percentage of delivered cost of corn.     

    Primary Logo

Опубликовать